Metformin Therapy for Type 2 Diabetes
Introduction to Metformin
- The American Diabetes Association recommends metformin as the preferred first-line pharmacological agent for type 2 diabetes due to its weight-neutral or weight-reducing effects, with modest weight loss of approximately 3-6% 1, 2
Weight Loss Efficacy
- Metformin achieves meaningful but modest weight reduction in patients with type 2 diabetes, with typical weight loss ranging from 3% of body weight, and 25-50% of patients achieving at least 5% weight loss 3
- Long-term data from the Diabetes Prevention Program showed 6.2% mean weight loss at 15-year follow-up compared to 2.8% with placebo 3
- Meta-analyses demonstrate metformin can reduce body weight while lowering HbA1c by 1.0-1.5% versus placebo 4
Mechanisms of Weight Effect
- Metformin decreases hepatic glucose production and lowers fasting glycemia 3
- Metformin increases insulin and leptin sensitivity 3
- Metformin decreases hunger and ghrelin levels, particularly with twice-daily dosing 3
Clinical Algorithm for Use
- The American Diabetes Association recommends initiating lifestyle modifications and adding metformin at or soon after diagnosis unless contraindicated, starting with 500 mg once or twice daily 1, 2, 3
- Titrate metformin gradually to 1500-2000 mg daily to minimize gastrointestinal side effects and maximize weight loss effect 3
Cardiovascular and Mortality Benefits
- Metformin provides a 32% reduction in microvascular and macrovascular diabetes-related outcomes 5
- Metformin provides a 39% reduction in myocardial infarction risk 5
- Metformin provides a 36% reduction in all-cause mortality 5
Absolute Contraindications
- Metformin is contraindicated in patients with eGFR <30 mL/min/1.73 m², hepatic dysfunction, severe infection or hypoxia, and conditions predisposing to lactic acidosis 3, 4
Required Monitoring
- Periodic vitamin B12 levels should be monitored, especially after 4-5 years of metformin use 3, 4
- Renal function should be monitored to ensure eGFR remains adequate 4, 5